Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
source https://www.sciencedaily.com/releases/2025/02/250205130931.htm
Rise of AI means companies could pass on SaaS
-
The writing is on the wall as AI companies race to add vertical
functionality
Software stocks have taken a beating over the last month as investors grow
...
19 hours ago
No comments:
Post a Comment